XBiotech
XBIT
$7.87
Share price
-4.14%
Change (1 day)
157.19%
Change (1 year)
Categories
Operating Margin for XBiotech (XBIT)
Operating Margin as of April 2024 (TTM): -860.09%
According to XBiotech's latest financial reports and stock price the company's current Operating Margin is -860.09%. At the end of 2021 the company had an Operating Margin of -138.40%.
Operating Margin history for XBiotech from 2020 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -138.40% | 374.73% |
| 2020 | -29.15% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 uniQure QURE | -120.45% | -86.00% | 🇳🇱 Netherlands |
 Calithera Biosciences
CALA | -1,180.38% | 37.24% | 🇺🇸 USA |
 Enzo Biochem ENZ | -43.44% | -94.95% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.